Pathogenesis and treatment of anaemia of chronic disease

Blood Reviews

Volumn 16, Issue 2, 2002, Pages 87-96

  Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anaemia of chronic disease; Erythropoiesis; Erythropoietin; Immune activation; Iron metabolism; Macrophage; Nitric oxide; Transfusion

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; FERRITIN; GAMMA INTERFERON; GROWTH FACTOR; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; IRON; NITRIC OXIDE; PROTOPORPHYRIN ZINC; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD TRANSFUSION; CANCER; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC DISEASE; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; ERYTHROPOIESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; IRON BLOOD LEVEL; IRON METABOLISM; IRON THERAPY; IRON TRANSPORT; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0036308047     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1054/blre.2002.0193     Document Type: Article

References (110)

1. Regulation of iron metabolism in eukaryotes
2. Molecular control of vertebrate iron metabolism: mRNA based regulatory circuits operated by iron, nitric oxide and oxidative stress
3. IRP-1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex elF4E
4. Two gene loci participate in the regulation by iron of the gene for human transferrin receptor
5. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmatic transferrin receptor mRNA
6. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages
7. Translational regulation via iron-responsive elements by nitric oxide/NO-synthase pathway
8. Rapid responses to oxidative stress mediated by iron regulatory protein
9. Regulation of iron metabolism in murine J774 macrophages: Role of nitric oxide dependent and independent pathways following activation with gamma interferon and lipopolysaccharide
10. Iron and lymphocytes: Reciprocal regulatory interactions
11. Iron in infection, immunity, inflammation and neoplasia
12. Linkage of cellular immunity to iron metabolism
13. Role of iron in T cell activation: Th-1 clones differ from Th-2 clones in their sensitivity to inhibition for DNA synthesis caused by IGG MAbs against transferrin receptor and the iron chelator desferrioxamine
14. Haemochromatosis as a window into the study of the immunological system in men: A novel correlation between CD8+ lymphocytes and iron overload
15. Iron release from human monocytes after erythrophagocytosis in vitro: An investigation in normal subjects and hereditary hemochromatosis patients
16. Iron acquisition by the reticuloendothelial system
17. Free radicals and phagocytic cells
18. The anaemia of chronic disorders
19. The anaemia of inflammation and chronic disease
20. Progress in understanding the pathogenesis of the anaemia of chronic disease
21. Iron and the anaemia of chronic disease
22. Analytical and clinical implications of soluble transferrin receptor in serum
23. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency
24. The expression of transferrin receptors on erythroblasts in anemia of chronic disease, myelodysplastic syndromes and iron deficiency
25. Zinc protoporphyrin in anemia of chronic disorders
26. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection
27. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor
28. Ferritin synthesis in inflammation. Mechanism of increased ferritin synthesis
29. The molecular cloning and characterization of ferritin heavy chain, a tumor necrosis factor inducible gene
30. Translational control during the acute phase response. Ferritin synthesis in response to interleukin I
31. Cloning and characterization of a mammalian proton-coupled metal-ion transporter
32. Interferon-gamma and lipopolysaccharide regulate the expression of Nramp2 and increase the uptake of iron from low relative molecular mass complexes by macrophages
33. Regulation of iron transport by inflammatory cytokines in human monocytic cells
34. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13
35. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: Changes in transferrin uptake, iron handling and ferritin mRNA
36. Regulation of transferrin receptor expression and ferritin content in human mononuclear macrophages. Coordinate upregulation by iron transferrin and downregulation by interferon gamma
37. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter
38. A novel duodenal iron-regulated transporter, IREG 1, implicated in the basolateral transfer of iron to the circulation
39. A novel mammalian iron-regulated protein involved in intracellular iron metabolism
40. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse
41. Regulation of iron metabolism in acute-phase response: Interferon-gamma and tumor necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients
42. Iron and Immunity - A two-sided sword
43. The acute-phase protein alpha I-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake
44. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes
45. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development
46. Immune activation and the anaemia associated with chronic inflammatory disorders
47. Nitric oxide suppression of human hematopoiesis in vitro
48. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line
49. Nitric oxide mediated inactivation of mammalian ferrochelatase in vivo and in vitro: Possible involvement of the iron-sulfur cluster of the enzyme
50. Altered iron metabolism in HIV infection: Mechanisms, possible consequences and proposals for management
51. Inhibition of in vitro erythropoiesis by soluble mediators of Plasmodium chabaudi AS malaria: Lack of a major role of interleukin 1, tumor necrosis factor alpha, and gamma interferon
52. H-ferritin: A regulatory cytokine that down-modulates cell proliferation
53. Decreased erythropoietin response in patients with anemia of cancer
54. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic onset juvenile chronic arthritis
55. Amemia in children with cancer is associated with decreased erythropoietin activity and not with inadequate erythropoietin production
56. Inhibition of human erythroid colony formation by IFN-gamma can be corrected by human recombinant erythropoietin
57. Nutrional deficiencies and blunted erythropoietin response as causes of anemia of critical illness
58. The pathogenesis of the anaemia of chronic disorders and the role of fever in erythrokinetics
59. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo
60. Human macrophage hemoglobin-iron metabolism in vitro
61. Activation of human monocyte functions by tumor necrosis factor. Rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release
62. Model of reticuloendothelial iron metabolism in human: Abnormal behaviour in idiopathic hemochromatosis and in inflammation
63. Iron withholding: A defense against infection and neoplasia
64. Body iron stores and the risk of cancer
65. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited
66. Role of iron in experimental Mycobacterium avium infection
67. The role of iron in cancer
68. Iron modulates interferon-gamma effects in human myelomonocytic cell line THP-1
69. Response of monocyte iron regulatory protein activity to inflammation: Abnormal behavior in genetic hemochromatosis
70. Iron overload alters T helper cell responses to Candida albicans in mice
71. Nitric oxide and macrophage function
72. Nitric oxide and the regulation of gene expression
73. Iron regulates nitric oxide synthase activity by controlling nuclear transcription
74. Functional requirement of the hypoxia responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine
75. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression
76. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria
77. Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria
78. Regulatory interactions between iron and nitric oxide metabolism for immune defense against plasmodium falciparum infection
79. Iron loading and disease surveillance
80. Understanding the multiple functions of NRAMP 1
81. Divalent metal transport by NRAMP proteins at the interface to host-pathogen interaction
82. A negative autoregulatory link between Nramp 1 function and expression
83. Asp169
84. Iron regulates the expression of a host resistance gene (NRAMP-1) in macrophages
85. Low-dose oral iron absorption test in anaemic patients with and without iron deficiency determined by bone marrow iron content
86. Pathobiology of the role of iron in infection
87. Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction?
88. Non-infectious complications of transfusion therapy
89. Effect of transfusional iron overload on immune response
90. Association between perioperative blood transfusion and postoperative infection in patietns having elective operations for gastrointestinal cancer
91. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia
92. Perioperative blood transfusion and cancer recurrence: Meta-analysis for explanation
93. Erythropoietin: A paradigm for the development of practice guidelines
94. Prediction of response to erythropoietin treatment in chronic anemia of cancer
95. Availability of iron and the degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis
96. Serum levels of erythropoietin and selected cytokines in patients with anemia of chronic disease
97. Pathogenesis of the anemia of chronic disease: A cytokine mediated anemia
98. Regulation of cellular iron metabolism by erythropoietin: Activation of iron regulatory protein and up-regulation of transferrin-receptor in erythroid cells
99. Complex regulation of transferrin receptors during erythropoietin-induced differentiation of J2E erythroid cells
100. Erythropoietin, iron and erythropoiesis
101. Regulation of the erythropoietin gene
102. Strategies for iron supplementation: Oral versus intravenous
103. Importance of iron supply for erythropoietin therapy
104. Reduction in recombinant human erythropoeitin doses by the use of chronic intravenous iron supplementation
105. Role of iron in optimizing responses of cancer patietns to erythropoietin
106. Hepcidin: A putative iron-regulatory hormone chronic disease
107. Erythropoeitin induces tumor regression and antitumor immuen response in murine myeloma models
108. Effects of Epoetin alpha on hematological parameters and quality of life in cancer patients receiving non-platinium chemotherapy. Results of a randomized, double blind, placebo controlled trial
109. Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis